References
Burstein D, Gray M, Hartman A, et al. Diffusion of small solutes in cartilage as measured by nuclear magnetic resonance (NMR) spectroscopy and imaging. J Othopaedic Res. 1993; 11: 465-478.
Fernandez-Canon JM, Granadino B, Beltran-Valero de Bernabe D, et al. The molecular basis of alkaptonuria. Nat Genet. 1996; 14: 19-24.
Gelse K, Ekici AB, Cipa F, et al. Molecular differentiation between osteophytic and articular cartilage—clues for transient and permanent chondrocyte phenotype. Osteoarthritis Cartil. 2012; 20: 162-171.
Huber M, Trattnig S, Lintner F. Anatomy, biochemistry, and physiology of articular cartilage. Investig Radiol. 2000; 35: 573-580.
Keller JM, Macaulay W. New developments in ochronosis: review of the literature. Rheumatol Int. 2004; 25: 81-85.
La Du BN, Zannoni VG, Laster L, et al. The nature of the defect in tyrosine metabolism in alcaptonuria. J Biol Chem. 1958; 230: 251-260.
Laschi M, Tinti L, Braconi D, et al. Homogentisate 1,2 dioxygenase is expressed in human osteoarticular cells: implications in alkaptonuria. J Cell Physiol. 2012; 227(9): 3254-3257.
Mannoni A, Selvi E, Lorenzini S, et al. Alkatonuria, ochronosis, and ochronotic arthropathy. Semin Arthritis Rheum. 2004; 33: 239-248.
Mistry JB, Bukhari M, Taylor AM. Alkaptonuria. Rare Dis. 2013; 1, e27475.
Phornphutkul C, Introne WJ, Perry MB, et al. Natural history of alkatonuria. N Engl J Med. 2002; 347: 2111-2121.
Roezilli P, Dethmers D, Rose D. Movement of interstitial water through loaded articular cartilage. J Biomechanics. 1983; 16: 169-179.
Ross MH, Pawlina W. “Cartilage.” Histology: A Text and Atlas: With Correlated Cell and Molecular Biology. Baltimore, MD: Lippincott Williams & Wilkins, 2006. 182–201.
Spreafico A, Millucci L, Ghezzi L, et al. Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria. Rheumatology (Oxford, England). 2013; 52(9): 1667-1673.
Taylor AM, Boyde A, Wilson PJM, et al. The role of calcified cartilage and subchondral bone in the initiation and progression of ochronotic arthropathy in alkaptonuria. Arthritis Rheum. 2011; 63(12): 3887-3896.
Taylor AM, Preston AJ, Paulk NK, et al. Ochronosis in a murine model of alkaptonuria is synonymous to that in a human condition. Osteoarthritis Cartil. 2012; 20: 880-886.
Taylor AM, Wlodarski B, Prior IA, et al. Ultrastructural examination of tissue in a patient with alkaptonuric arthropathy reveals a distinct pattern of binding of ochronotic pigment. Rheumatology (Oxford). 2010; 49: 1412-1414.
Tinti L, Taylor AM, Santucci A, et al. Development of an in vitro model to investigate joint ochronosis in alkaptonuria. Rheumatology (Oxford). 2011; 50(2): 271-277.
Yamada T, Yamamoto T, Shida J, et al. Subchondral insufficiency fracture of the femoral head in a patient with alkaptonuria. Skeletal Radiol. 2014; 43: 827-830.
Zannoni VG, Lomtevas N, Goldfinger S. Oxidation of homogentisic acid to ochronotic pigment in connective tissue. Biochim Biophys Acta. 1969; 177(1): 94-105.
Disclosures
Conflict of Interest
Vincent W. Vigorita, Paul D. Marino, BA, and Paul A. Lucas, PhD received institutional research grant support from the New York Community Trust for the study.
Human/Animal Rights
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5).
Informed Consent
N/A
Required Author Forms
Disclosure forms provided by the authors are available with the online version of this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vigorita, V.W., Marino, P.D. & Lucas, P.A. The Distribution of Ochronosis in Osteoarthritic Articular Cartilage in a Knee. HSS Jrnl 12, 76–80 (2016). https://doi.org/10.1007/s11420-015-9464-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11420-015-9464-6